New partners Wenzel Spine and Safe Group join forces during

  • Co-promotion of Wenzel and Safe technologies in NASS
  • Inventory delivered to Wenzel Spine for first cases

Eragny-sur-Oise, France, Austin, Texas, USA, October 11e2022, 5:45 p.m. CET – Safe (FR0013467123 – ALSAF)a company specializing in the design, manufacture and marketing of ready-to-use technologies and services for spine surgeries, and Wenzel Spine, a medical technology company focused on providing surgical and diagnostic solutions mini- for the treatment of spinal disorders, having recently signed two commercial agreements, are joining forces at the North American Spine Society (NASS) meeting in Chicago on October 11-14, 2022.

The recent strategic partnership between Wenzel Spine and Safe Group will result in the formation of a new service delivery model that will include Safe’s off-the-shelf technologies (minimally invasive pedicle screws and spinal augmentation technologies) and Wenzel Spine implants and diagnostic solutions, providing clinical, cost-effective, and streamlined solutions for surgeons, especially unique for surgeons performing spine procedures in Ambulatory Surgical Centers (ASCs) and ambulatory care facilities in the United States .

Safe Orthopedics has already delivered storage inventory of SteriSpine PS and SteriSpine VA to Wenzel Spine to begin surgeries after the NASS Congress.

Smart scaling

Wenzel Spine and Safe Group are open to meeting and collaborating with orthopedic surgeons and neurosurgeons during NASS who wish to evolve their practices to meet the growing demand for ASC/ambulatory spine procedures, by implementing a solution smart scaling that requires less resources, but results in value equivalence compared to other more resource-intensive solutions. Enabling surgeons to expand their practices with a comprehensive, patient-centered, service-based delivery model will be the synergistic effect of their mutual collaboration.

“Wenzel Spine received our inventory from Safe Orthopedics earlier this week and we are ready to begin working with our partners with the expanded solutions that are immediately available.” said William Wilson, co-founder and CEO of Wenzel Spine. “Accelerating our growth in the acute care and ambulatory fusion market with Safe’s ready-to-use solutions in conjunction with Wenzel’s products will increase the value of our service offerings for our customers and especially patients. they deal with.”

Pierre Dumouchel, Chairman and CEO of Safe Group, adds: “The NASS congress is the ideal event to explain the benefits of our collaboration with Wenzel Spine. By joining our sales and marketing forces, we hope to convince our existing customers to use our consolidated portfolios of technologies and services and to attract new surgeons acting in ambulatory or ambulatory settings. We plan to accelerate our sales growth in the short term and will continue to analyze options in the medium term to maximize synergies between the needs of Wenzel and Safe surgeons and ambulatory or outpatient center projects.

better together

Wenzel Spine is focused on providing new MIS and diagnostic solutions for the treatment of low back and neck disorders, with S-LIF using VariLift®-LX and S-ACDF using VariLift®-C—true stand-alone fusion alternatives MIS according to their needs no additional fixings such as rods, screws or plates. VariLift-LX is the only FDA-cleared posterior self-contained posterior lumbar interbody fusion device on the market that requires significantly less hardware to promote fusion while prioritizing the preservation of healthy anatomy. Wenzel Spine technologies are currently only available in the United States.

Wenzel Spine’s solutions have been used by over 300 surgeons in 39 states across the United States. With access to over 2,000 hospitals and ASCs and backed by a strong distribution network, Wenzel Spine has seen outpatient revenues soar 196% post-COVID. With a shared vision to provide more unique treatment options to surgeons and their patients, Wenzel Spine and Safe Orthopedics will immediately begin distributing Safe Orthopedics’ off-the-shelf technologies (MIS Pedicle Screws and Spinal Augmentation Technologies) and Wenzel Spine implants across the United States. .

Safe group specializes in the design, manufacture and marketing of single-use technologies for spine surgeries, using a minimally invasive approach aimed at reducing the risk of contamination and infection. The company’s patented SteriSpineMT the kits are CE marked and FDA cleared.

Safe Medical, the group’s medical device contractor for orthopedic surgery, will support the design of ready-to-use technologies and the manufacturing of Wenzel Spine products. The products will be manufactured at CIPI* in Fleurieux-sur-l’Arbresle, offering industrial machining, finishing and packaging services. Optimizing the cost of technologies with Safe Medical and developing ready-to-use instrument sets for Wenzel Spine implants will initiate distribution across Europe.

About Safe Group
Safe Group is a French medical technology group that brings together Safe Orthopedics, a pioneer in ready-to-use technologies for spine pathologies, and Safe Medical (formerly LCI Medical), a subcontractor of medical devices for orthopedic surgery. The group employs around 150 people.

Safe Orthopedics develops and manufactures kits combining sterile implants and single-use instruments, available to the surgeon at any time. These technologies are part of a minimally invasive approach aimed at reducing the risks of contamination and infection, in the interest of the patient and with a positive impact on hospitalization times and costs. Protected by 18 patent families, SteriSpineTM kits are CE marked and FDA approved. Safe Orthopedics has its head office in the Paris region (
95610 Eragny-sur-Oise) and has subsidiaries in the United Kingdom, Germany, the United States and in the Lyon region (Fleurieux-sur-l’Arbresle).

For more information: http://www.safeorthopedics.com/

Safe Medical produces implantable medical devices and ready-to-use instruments. It has an innovation center and two production sites in France (Fleurieux-sur-l’Arbresle, 69210) and in Tunisia, offering numerous industrial services: design, industrialization, machining, finishing and sterile packaging. Supported by the French recovery plan in 2020, the company is investing in additive printing and will be operational in 2022 on this new technology.

For more information: http://www.safemedical.fr/

About Wenzel Spine, Inc.
Wenzel Spine, Inc. is a medical technology and services company focused on providing minimally invasive solutions for the treatment of spinal disorders. Based in Austin, TX, Wenzel Spine is focused on providing surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time. Wenzel Spine seeks to improve the quality of life of patients by designing and producing the highest quality devices to support our surgeon customers in the care and treatment of their patients.

For more company and product information, visit www.wenzelspine.com.

contacts

Wenzel spine
William Wilson
Chief executive officer
512-469-6066
[email protected]

Safe group
Francois-Henri Reynaud
Financial and Administrative Director
Such. : +33 (0)1 34 21 50 00
[email protected]

  • 20221011_PR- NASS Wenzel Safe

Comments are closed.